Mezzion Pharma Co.,Ltd. (KOSDAQ: 140410)
South Korea
· Delayed Price · Currency is KRW
31,400
+1,050 (3.46%)
Jan 3, 2025, 9:00 AM KST
Mezzion Pharma Co.,Ltd. Cash Flow Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
Net Income | -14,223 | -12,728 | -36,298 | -13,603 | -13,829 | -23,251 | Upgrade
|
Depreciation & Amortization | 1,115 | 1,546 | 1,658 | 1,586 | 1,432 | 1,332 | Upgrade
|
Loss (Gain) From Sale of Assets | 54.52 | -7.36 | -8.99 | 1.08 | 23.92 | - | Upgrade
|
Asset Writedown & Restructuring Costs | - | - | 14,694 | - | - | - | Upgrade
|
Loss (Gain) From Sale of Investments | - | - | - | - | -26.76 | -14.25 | Upgrade
|
Stock-Based Compensation | 850.45 | 421.61 | 1,293 | 2,535 | 1,132 | 2,269 | Upgrade
|
Provision & Write-off of Bad Debts | 99.62 | 87.18 | -20.93 | -124.47 | 66.87 | -210.03 | Upgrade
|
Other Operating Activities | 1,129 | -1,128 | 677.64 | -4,327 | 7,026 | -493.48 | Upgrade
|
Change in Accounts Receivable | 2,175 | 245.93 | -150.7 | 308.73 | 234.24 | -1,131 | Upgrade
|
Change in Inventory | 750.67 | 2,643 | -313.17 | -4,786 | -3,952 | -715.77 | Upgrade
|
Change in Accounts Payable | -3,466 | -3,152 | 1,474 | 1,780 | -80.27 | 1,596 | Upgrade
|
Change in Other Net Operating Assets | -7,672 | 1,048 | 4,921 | 1,558 | 596.37 | -261 | Upgrade
|
Operating Cash Flow | -19,186 | -11,023 | -12,075 | -15,071 | -7,377 | -20,880 | Upgrade
|
Capital Expenditures | -744.71 | -529.29 | -767.56 | -357.81 | -774.25 | -1,098 | Upgrade
|
Sale of Property, Plant & Equipment | 62.72 | 77.72 | 9.2 | - | 8.5 | - | Upgrade
|
Cash Acquisitions | 1,192 | 1,192 | - | - | - | - | Upgrade
|
Sale (Purchase) of Intangibles | -12,987 | -11,329 | -993.47 | -5,825 | -7,182 | - | Upgrade
|
Investment in Securities | 8,714 | -14,967 | 19,157 | -10,151 | 11,509 | 5,215 | Upgrade
|
Other Investing Activities | 0 | 0 | 5.11 | -0 | - | -3,813 | Upgrade
|
Investing Cash Flow | -3,763 | -25,555 | 17,410 | -16,334 | 3,561 | 304.47 | Upgrade
|
Short-Term Debt Issued | - | 3,226 | 4,832 | 3,744 | 3,841 | - | Upgrade
|
Total Debt Issued | 1,640 | 3,226 | 4,832 | 3,744 | 3,841 | - | Upgrade
|
Short-Term Debt Repaid | - | -3,776 | -4,603 | -3,786 | -3,263 | - | Upgrade
|
Long-Term Debt Repaid | - | -888.69 | -1,157 | -1,071 | -1,085 | -1,052 | Upgrade
|
Total Debt Repaid | -2,837 | -4,665 | -5,760 | -4,857 | -4,348 | -1,052 | Upgrade
|
Net Debt Issued (Repaid) | -1,196 | -1,439 | -927.79 | -1,114 | -506.62 | -1,052 | Upgrade
|
Issuance of Common Stock | - | 48,653 | 312 | 225.77 | 24,515 | 7,813 | Upgrade
|
Repurchase of Common Stock | -2,115 | - | - | - | - | - | Upgrade
|
Other Financing Activities | 4,000 | -0 | - | 20,000 | - | -0 | Upgrade
|
Financing Cash Flow | 688.7 | 47,214 | -615.79 | 19,112 | 24,008 | 6,762 | Upgrade
|
Foreign Exchange Rate Adjustments | 485.73 | 211.86 | 470.01 | 648.86 | 16.75 | -93.2 | Upgrade
|
Net Cash Flow | -21,774 | 10,847 | 5,189 | -11,644 | 20,210 | -13,907 | Upgrade
|
Free Cash Flow | -19,931 | -11,553 | -12,842 | -15,429 | -8,151 | -21,978 | Upgrade
|
Free Cash Flow Margin | -141.58% | -36.42% | -41.80% | -57.89% | -28.47% | -122.64% | Upgrade
|
Free Cash Flow Per Share | -669.19 | -409.10 | -480.39 | -578.14 | -313.46 | -846.15 | Upgrade
|
Cash Interest Paid | 405.72 | 220.24 | 26.77 | 7.99 | 9.31 | 877.61 | Upgrade
|
Cash Income Tax Paid | 722.52 | 209.5 | 397.25 | 1,531 | 129.23 | 2,283 | Upgrade
|
Levered Free Cash Flow | -29,181 | -17,965 | -3,264 | -17,413 | -11,123 | -21,516 | Upgrade
|
Unlevered Free Cash Flow | -28,962 | -17,768 | -2,999 | -17,211 | -10,923 | -21,317 | Upgrade
|
Change in Net Working Capital | 7,854 | -1,599 | -11,686 | 2,116 | -307.42 | 6,249 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.